These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. B lymphocytes are required for development and treatment of autoimmune diseases. Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517 [TBL] [Abstract][Full Text] [Related]
23. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization. Kuipers H; Heirman C; Hijdra D; Muskens F; Willart M; van Meirvenne S; Thielemans K; Hoogsteden HC; Lambrecht BN J Leukoc Biol; 2004 Nov; 76(5):1028-38. PubMed ID: 15316032 [TBL] [Abstract][Full Text] [Related]
24. TH1-TH2: a procrustean paradigm. Gor DO; Rose NR; Greenspan NS Nat Immunol; 2003 Jun; 4(6):503-5. PubMed ID: 12774069 [No Abstract] [Full Text] [Related]
25. Regulatory T cells control the development of allergic disease and asthma. Umetsu DT; Akbari O; Dekruyff RH J Allergy Clin Immunol; 2003 Sep; 112(3):480-7; quiz 488. PubMed ID: 13679803 [TBL] [Abstract][Full Text] [Related]
26. Alterations of TH1/TH2 reactivity by heavy metals: possible consequences include induction of autoimmune diseases. Hemdan NY; Emmrich F; Faber S; Lehmann J; Sack U Ann N Y Acad Sci; 2007 Aug; 1109():129-37. PubMed ID: 17785298 [TBL] [Abstract][Full Text] [Related]
27. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases. Echigo T; Hasegawa M; Shimada Y; Inaoki M; Takehara K; Sato S Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210 [TBL] [Abstract][Full Text] [Related]
29. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Sun CM; Deriaud E; Leclerc C; Lo-Man R Immunity; 2005 Apr; 22(4):467-77. PubMed ID: 15845451 [TBL] [Abstract][Full Text] [Related]
30. In search of the CTD. Murphy KM Nat Immunol; 2003 Jul; 4(7):645. PubMed ID: 12830141 [No Abstract] [Full Text] [Related]
31. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Kuipers H; Lambrecht BN Curr Opin Immunol; 2004 Dec; 16(6):702-8. PubMed ID: 15511661 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of T-bet in T cells accelerates autoimmune glomerulonephritis in mice with a dominant Th1 background. Shimohata H; Yamada A; Yoh K; Ishizaki K; Morito N; Yamagata K; Takahashi S J Nephrol; 2009; 22(1):123-9. PubMed ID: 19229827 [TBL] [Abstract][Full Text] [Related]
37. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Sallusto F; Lanzavecchia A; Mackay CR Immunol Today; 1998 Dec; 19(12):568-74. PubMed ID: 9864948 [No Abstract] [Full Text] [Related]
38. Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses. Mantovani A; Allavena P; Vecchi A; Sozzani S Int J Clin Lab Res; 1998; 28(2):77-82. PubMed ID: 9689547 [TBL] [Abstract][Full Text] [Related]
39. T-cell subsets: recruiting the right kind of help. Lichtman AH; Abbas AK Curr Biol; 1997 Apr; 7(4):R242-4. PubMed ID: 9162501 [TBL] [Abstract][Full Text] [Related]
40. Potential alterations in immunogenicity by combining or simultaneously administering vaccine components. Insel RA Ann N Y Acad Sci; 1995 May; 754():35-47. PubMed ID: 7625671 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]